Three-armed trial to study new regimens for advanced gastric/esophageal cancer

Oncology Report

Volumn , Issue SPRING, 2005, Pages 121-122

  Moore, Malcolm J ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; CISPLATIN; DOCETAXEL; EPIRUBICIN; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADD ON THERAPY; ADVANCED CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; DRUG RESPONSE; ESOPHAGUS CANCER; EUROPE; FEBRILE NEUTROPENIA; GASTROINTESTINAL TRACT FUNCTION; HUMAN; MALNUTRITION; METASTASIS; NEUTROPENIA; NOTE; STATISTICAL ANALYSIS; STOMACH CANCER;

EID: 16844369209     PISSN: 15485323     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (1)

1. Ilson DH. Emerging standard of care in gastroesophageal cancer. Paper presented at the 22nd Chemotherapy Foundation Symposium; November 9-13, 2004; New York, NY.